NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)
Stock · NASDAQ · Health Care
$25.9as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$29.66
Industry
Biotechnology: Pharmaceutical Preparations
About NAMS
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 100
- Website
- ir.newamsterdampharma.com/
Fundamentals
- 1-day range
- $25.53$26.88
- Market cap
- $3.23B
- P/E (trailing)
- —
- P/E (forward)
- -16.50
- EPS (trailing)
- $-2.15
- Dividend yield
- —
- Beta
- 0.08
- Avg. volume
- 1.12M
52-week range
$23.05$42.21
Next earnings: November 4, 2026 · EPS estimate $-0.45Before Openconfirmed
How NewAmsterdam Pharma Company N.V. Ordinary Shares Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 18, 2026 · via SEC EDGAR / Finnhub
Forecasts
15 analyst ratings
Buy 91%
Hold 9%
Sell 0%
1-year price forecast
High
$60.22
+132.5%
Median
$52.19
+101.5%
Low
$38.14
+47.2%
NewAmsterdam Pharma Company N.V. Ordinary Shares Competitors
Chosen by industry and closest market cap.
- NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares$25.9▼ 3.32%Market cap $3.23BP/E —$23.05$42.21
- MBXMBX Biosciences Inc. Common Stock$63.04▼ 5.05%Market cap $3.19BP/E —$9.63$72.64
- ARQTArcutis Biotherapeutics Inc. Common Stock$23.78▼ 4.38%Market cap $3.31BP/E 113.86$15.1$31.77
- IRONDisc Medicine Inc. Common Stock$80.01▼ 3.08%Market cap $2.97BP/E —$40$99.5
- ALMSAlumis Inc. Common Stock$22.38▼ 3.58%Market cap $3.54BP/E —$3.76$31.35
- IMNMImmunome Inc. Common Stock$27.57▼ 4.50%Market cap $2.92BP/E —$8.67$30.06
- TLXTelix Pharmaceuticals Limited American Depositary Shares$11.28▼ 0.84%Market cap $3.60BP/E —$6.28$12.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares | $3.23B | — | $25.9 | ▼ 3.32% | $23.05$42.21 |
| MBX MBX Biosciences Inc. Common Stock | $3.19B | — | $63.04 | ▼ 5.05% | $9.63$72.64 |
| ARQT Arcutis Biotherapeutics Inc. Common Stock | $3.31B | 113.86 | $23.78 | ▼ 4.38% | $15.1$31.77 |
| IRON Disc Medicine Inc. Common Stock | $2.97B | — | $80.01 | ▼ 3.08% | $40$99.5 |
| ALMS Alumis Inc. Common Stock | $3.54B | — | $22.38 | ▼ 3.58% | $3.76$31.35 |
| IMNM Immunome Inc. Common Stock | $2.92B | — | $27.57 | ▼ 4.50% | $8.67$30.06 |
| TLX Telix Pharmaceuticals Limited American Depositary Shares | $3.60B | — | $11.28 | ▼ 0.84% | $6.28$12.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- NewAmsterdam Pharma Company N.V. (NAMS) Analyst/Investor Day TranscriptSeekingAlpha · 8/8/2026
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo · 8/6/2026
- RBC Capital Maintains Outperform on NewAmsterdam Pharma Co, Lowers Price Target to $50Benzinga · 8/6/2026
- NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim NearsYahoo · 8/5/2026
- NewAmsterdam Pharma Company N.V. (NAMS) Analyst/Investor Day - SlideshowSeekingAlpha · 8/5/2026
- NewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Lags Revenue EstimatesYahoo · 8/5/2026
- NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial ResultsYahoo · 8/5/2026
- NewAmsterdam Pharma Q2 EPS $(0.52) Misses $(0.48) Estimate, Sales $3.701M Beat $1.663M EstimateBenzinga · 8/5/2026
Insider Activity
Insider Actions →Acquired
254.6K
Disposed
254.6K
- Louise Frederika Kooij · July 20, 2026 · Option Exercise80.0K @ $11.17
- Louise Frederika Kooij · July 20, 2026 · Option Exercise25.0K @ $11.9
- Louise Frederika Kooij · July 20, 2026 · Sale2.9K @ $31.71
- Louise Frederika Kooij · July 20, 2026 · Sale31.9K @ $31.05
- Louise Frederika Kooij · July 20, 2026 · Sale70.2K @ $29.96
- Louise Frederika Kooij · June 22, 2026 · Option Exercise15.0K @ $11.9
- Louise Frederika Kooij · June 22, 2026 · Option Exercise25.0K @ $10.9
- Louise Frederika Kooij · June 22, 2026 · Sale300 @ $30.73
- Louise Frederika Kooij · June 22, 2026 · Sale39.7K @ $30.2
- Louise Frederika Kooij · May 26, 2026 · Option Exercise5.0K @ $10.9
- Louise Frederika Kooij · May 26, 2026 · Option Exercise60.0K @ $10
- Louise Frederika Kooij · May 26, 2026 · Sale65.0K @ $35.69
- Louis G. Lange · March 11, 2026 · Sale446 @ $31.23
- Louis G. Lange · March 11, 2026 · Sale44.2K @ $30.41
- Louis G. Lange · March 9, 2026 · X44.6K @ $11.5
See the full, filterable feed with live charts on the MarketWall dashboard.